2.32 USD
↗ 0.00 (0.00%)AT CLOSE (AS OF 08:01 PM EDT)
TuHURA Biosciences, Inc. Common Stock
HURANASDAQ • USD
Market: CLOSED
Open?$2.43
High?$2.58
Low?$2.29
Prev. Close?$2.31
Volume?614.4K
Avg. Volume?1.1M
VWAP?$2.35
Rel. Volume?0.54x
Bid / Ask
Bid?$2.22 × 1.7K
Ask?$2.45 × 1.0K
Spread?$0.23
Midpoint?$2.34
Valuation & Ratios
Market Cap?147.1M
Shares Out?N/A
Float?32.2M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?7.03
EPS?-$0.47
Dividend?0.01%
Ex-Dividend?N/A
News
Profile
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Employees
22
Market Cap
147.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-18
Address
10500 UNIVERSITY CENTER DR.
TAMPA, FL 33612
Phone: 813-875-6600
TAMPA, FL 33612
Phone: 813-875-6600
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.78Weak
Quick Ratio?0.78Weak
Cash Ratio?0.61Adequate
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?7.03FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.1CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-143.6%WEAK▾
ROA?-109.9%WEAK▾
Cash Flow & Enterprise
FCF?$-27705233
Enterprise Value?$143.7M
Fundamentals ratios updated end of day